5 Interesting Tidbits In iRhythm’ $86M IPO Registration

Medical device company iRhythm Technologies last week filed for an $86 million initial public offering. The San Francisco-based maker of a wearable heart monitor called the Zio expects to use the cash to expand the device’s clinical reach.

The FDA-cleared device is worn as a patch and continuously logs heartbeat data for 14 days to look for irregular heart rhythm. Combined with a cloud-based data platform, the device makes up one-half of an overall Zio service that enables physicians to monitor patients and diagnose arrhythmias.

Back to news